Enhanced Antitumor Efficacy of Oncolytic Adenovirus-Loaded Menstrual Blood-Derived Mesenchymal Stem Cells in Combination With Peripheral Blood Mononuclear Cells.

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0431

Related search